{"id":"W4379281872","doi":"10.1200/jco.2023.41.16_suppl.7555","title":"Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma.","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Internal medicine; Clinical endpoint; Adverse effect; Follicular lymphoma; Regimen; Phases of clinical research; Refractory (planetary science); Surgery; Lymphoma; Gastroenterology; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003277403,0.0006859615,0.001186245,0.0005908115,0.0004212174,0.001165086,0.0005159184,0.0006755908,0.001360441],"category_scores_gemma":[0.002187937,0.0003092106,0.001419289,0.0005968727,0.0004031357,0.0006660324,0.0004065632,0.001471003,0.0003730896],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001360386,"about_ca_system_score_gemma":0.001090974,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001133169,"about_ca_topic_score_gemma":0.003184007,"domain_scores_codex":[0.9989857,0.000320791,0.00009528288,0.0001844616,0.0002779489,0.0001358013],"domain_scores_gemma":[0.9978437,0.0002879618,0.000905206,0.0001499889,0.0002240878,0.0005889094],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4424564,0.01155213,0.2704494,0.001582875,0.009196068,0.001153385,0.0006538447,0.005264079,0.02361502,0.000535748,0.02355574,0.2099854],"study_design_scores_gemma":[0.1162897,0.1714301,0.6794896,0.0002404879,0.006667341,0.002057951,0.0002109173,0.002921872,0.003504161,0.0003876651,0.01665528,0.0001449129],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828455,0.008899978,0.0003087793,0.0003286543,0.00005843031,0.0003989557,0.004044606,0.00006112118,0.003053994],"genre_scores_gemma":[0.9837332,0.002115883,0.0004803687,0.0009191757,0.0001602769,0.000368043,0.01127247,0.00001831894,0.0009322142],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003277403,"threshold_uncertainty_score":0.01733279,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0552513847129782,"score_gpt":0.3780557654255918,"score_spread":0.3228043807126136,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}